-Genzou Takemura Researcher Activity Profile

Research Author Detailed Information 

Genzou Takemura Publication Rate By Year

Genzou Takemura has published 11 paper(s) in 2007, 3 paper(s) in 2008, for a total of 14 research publications in total.

Genzou G Takemura Author Information

LAST NAME: takemura

FIRST NAME: genzou

INITIALS: G

AFFILIATION:

Papers

Genzou Takemura's Publication Record

1. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
2. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
3. Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
4. [Postinfarction heart failure] Year Published: 2007
Division of Cardiology, Gifu University School of Medicine.
5. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Year Published: 2007
Department of Internal Medicine, Chuno Kosei Hospital, Gifu, Japan.
6. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Year Published: 2007
Department of Internal Medicine, Chuno Kosei Hospital, Gifu, Japan.
7. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Year Published: 2007
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
8. [Postinfarction heart failure] Year Published: 2007
Division of Cardiology, Gifu University School of Medicine.
9. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Year Published: 2007
Department of Cardiology, Regeneration and Advanced Medical Science, Gifu University, Gifu, Japan.
10. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Year Published: 2007
Department of Cardiology, Regeneration and Advanced Medical Science, Gifu University, Gifu, Japan.
11. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. Year Published: 2007
Department of Cardiology, Regeneration and Advanced Medical Science, Gifu University, Gifu, Japan.
12. Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. Year Published: 2008
Div. of Cardiology, Gifu Univ. Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan. gt@gifu-u.ac.jp).
13. Development of integrated backscatter intravascular ultrasound for tissue characterization of coronary plaques. Year Published: 2008
Regeneration and Advanced Medical Science, Gifu University Graduate School of Medicine, Gifu, Japan.
14. Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. Year Published: 2008
Division of Cardiology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu 501-1194, Japan.